Background-The molecular mechanisms underlying similarities and differences between physiological and pathological left ventricular hypertrophy (LVH) are of intense interest. Most previous work involved targeted analysis of individual signaling pathways or screening of transcriptomic profiles. We developed a network biology approach using genomic and proteomic data to study the molecular patterns that distinguish pathological and physiological LVH. Methods and Results-A network-based analysis using graph theory methods was undertaken on 127 genome-wide expression arrays of in vivo murine LVH. This revealed phenotype-specific pathological and physiological gene coexpression networks. Despite >1650 common genes in the 2 networks, network structure is significantly different. This is largely because of rewiring of genes that are differentially coexpressed in the 2 networks; this novel concept of differential wiring was further validated experimentally. Functional analysis of the rewired network revealed several distinct cellular pathways and gene sets. Deeper exploration was undertaken by targeted proteomic analysis of mitochondrial, myofilament, and extracellular subproteomes in pathological LVH. A notable finding was that mRNA-protein correlation was greater at the cellular pathway level than for individual loci.
H earts under chronic hemodynamic disease stress develop pathological left ventricular hypertrophy (LVH), a complex remodeling response that predisposes to heart failure. 1 Pathological remodeling is associated with interstitial fibrosis, cardiomyocyte apoptosis, contractile dysfunction, and arrhythmia. 2 The heart also remodels with chronic exercise or pregnancy, but such physiological LVH is unaccompanied by fibrosis, apoptosis, or significant contractile dysfunction and carries no risk of failure. 3 Delineation of the molecular mechanisms driving these divergent responses may inform therapeutic strategies for pathological LVH and heart failure. Much work has focused on targeted investigation of specific signaling pathways in the pathogenesis of physiological or pathological LVH and revealed novel insights. 1 However, few novel therapies have emerged, and complementary approaches for target discovery need to be considered. 4 
Clinical Perspective on p 597
Network-based analyses of disease phenotypes involve systems-level characterization of biological mechanisms to uncover the complex relationships between genes or proteins and their environment. 5 Analysis of the functional architecture of gene and protein networks that orchestrate disease development might provide a useful foundation for novel therapeutic approaches. 6 Indeed, such approaches have begun to yield positive results in areas such as oncology, 7 but have only recently been applied to cardiac disease. 8, 9 Previous studies used microarray experiments to explore gene expression differences in cardiac hypertrophy. 10 Such studies reported that genes associated with pathological hypertrophy included inflammatory, apoptotic, fetal reprogramming, and oxidative stress pathways whereas genes associated with physiological hypertrophy affected metabolism and insulin signaling. 11 However, a global framework of the mechanisms driving similarities and differences between these phenotypes is lacking.
We developed a network-based genomic and proteomic framework for comparing gene coexpression networks underlying pathological and physiological LVH. Comprehensive characterization of network properties allowed us to identify that a large number of genes were differentially wired in pathological LVH. Integration of transcriptomic data of pathological LVH with a proteomic analysis of mitochondrial, myofilament, and extracellular subproteomes allowed the establishment of geneprotein relationships for individual loci and entire pathways. This comprehensive analysis at transcriptome and proteome levels reveals novel insights into the molecular basis of pathological versus physiological LVH and provides a resource for further studies of genotype-phenotype relationships in this condition.
Methods
Detailed methods are provided in the online-only Data Supplement.
Gene Expression Analysis
Six mouse microarray data sets (n=127 arrays) were obtained from ArrayExpress (Table 1) . 12 Raw gene expression was processed using robust multi-array average, and each array was inspected for outlying samples. Affymetrix probe identifiers were mapped to corresponding Entrez gene identifiers. 13 
Graph Theory Methods

Reverse Engineering Gene Coexpression Networks
Gene coexpression networks were reconstructed by expressing pairwise similarity in expression profiles by the Pearson correlation coefficient (PCC). Gene pairs that correlated above a predefined PCC threshold were represented as an undirected unweighted network, where nodes correspond to genes and links (edges) correspond to coexpression between genes. We used a data-driven computational method to calculate the appropriate PCC threshold for each microarray data set.
Network Topology
Node degree denotes the number of links a node has to other nodes. Nodes with high degree in biological networks (or hubs) are reported to be essential for processes such as cell survival. 14 Betweenness centrality is the number of shortest paths that pass through a node. Nodes with the highest betweenness represent the critical points of information flow within a network. Eigenvector centrality is a measure of overall network connectivity, denoting connections of nodes to other nodes that are central within the network. Clustering coefficient represents the number of node neighbors that are also interconnected. In protein-protein interaction networks, genes harboring disease-causing mutations tend to be distant from dense-clustering neighborhoods. 15 The shortest path is the shortest distance connecting any 2 genes. The diameter is the longest short path between any pair of genes in the network.
Gene Rewiring
The number of connections of each gene (node degree) was scaled to a value between 0 and 1 by dividing each node degree by the largest degree in a network. Differential wiring of genes common to pathological and physiological networks was computed by subtracting the node degree in the physiological network from node degree in the pathological network. 16 Thus, genes with positive rewiring are more central in the pathological network compared with physiological network.
Animal Studies
Procedures were performed in accordance with the Guidance on the Operation of the Animals (Scientific Procedures) Act, 1986 (United Kingdom). Aortic constriction (AC) and running exercise were performed as described. 17, 18 
Reverse Transcription Polymerase Chain Reaction
RNA was isolated from 22 mouse LV samples (wild type [WT]-sham: n=6; AC: n=6; WT-sedentary: n=5; WT-running: n=5). Transcript expression was quantified using TaqMan probes (Applied Biosystems).
Nanoflow Liquid Chromatography-Tandem Mass Spectrometry
Liquid chromatography-tandem mass spectrometry analyses of LVs from 4 WT sham-operated mice, 4 angiotensin IIinduced hypertrophy, and 4 LVs after AC were performed as described, 19 with modifications. We used a novel protocol that enriches extracellular matrix (ECM) 19 and myofilament 20 proteins (Methods in the online-only Data Supplement).
Statistical Analysis
Differential expression analysis was performed by fitting a linear model with empirical Bayes shrinkage to the log intensities of expression values for each gene. 21 P values were adjusted to control the expected false discovery rate using Benjamini-Hochberg correction. False discovery rate-controlled values of P<0.05 were considered significant.
Results
Construction of the LVH Networks
After data preprocessing and outlier removal (Methods in the online-only Data Supplement), our analysis included 124 samples from 6 mouse microarray data sets in different models of pathological and physiological LVH ( Table 1) . For each data set, we created a gene coexpression matrix of pairwise PCC ( Figure I in the online-only Data Supplement). Only gene pairs with significant coexpressions were considered. Because all LVH networks contained a large number of edges (≤3.3 million; Table 1 ), nodes and edges that may arise because of experimental variability were filtered through intersection of networks. The intersection of the 3 pathological networks contained 3634 genes and 13 558 links (pathological, Tables I and III in the online-only Data Supplement) whereas the intersection of the 3 physiological networks produced comparable numbers, namely, 3156 genes and 4486 links (physiological, Tables II and IV in the online-only Data Supplement; Figure 1A ). These intersections were compared against a random background by shuffling edges in the original networks 200× while preserving their degrees and then calculating their intersections. Intersections of randomized pathological and physiological hypertrophy networks contained an average of 3882.9 (SD=91.2) and 3312.6 (SD=77.7) links, respectively. Thus, the identification of 13 558 and 4486 conserved coexpressions in the real pathological and physiological networks was considered a nonrandom instance against the simulated background (z score=106.13 and 15.1, respectively; Figure 1A -1D).
Hypertrophy Networks Are Phenotype Specific
We tested the phenotype specificity of the pathological and physiological networks by enriching the gene sets for established mouse mutant phenotypes using the MamPhEA tool. 22 Pathological network genes were enriched for phenotypes including cardiovascular system phenotype (adjusted P=1.6×10 −7 ), prenatal lethality (adjusted P=2.9×10 −6 ), abnormal cardiovascular system morphology (adjusted P=5.3×10 −6 ), and abnormal blood vessel morphology (adjusted P=5.7×10 −4 ) whereas physiological network genes were enriched primarily for prenatal lethality (P=4.9×10 −6 ; Figure 2A and 2B). Thus, the derived gene networks obtained through computational integration of the microarray expression data reflect the cardiovascular phenotype.
We examined whether the genes contributing to the cardiovascular phenotype are more connected than other genes in the pathological and physiological networks. We identified 19 and 6 layers of differential connectivity in the pathological and physiological networks, respectively, by peeling 23 each gene network (Methods in the online-only Data Supplement). These layers reflect gene connectivity neighborhoods such that the first peeled layer contains genes with only a few connections whereas the last layer contains the most connected genes ( Figure II in the online-only Data Supplement). Interestingly, pathological network cardiovascular genes (≈22%) localized to the intermediate (layers 9-10) but not dense layers ( Figure 2C ). Conversely, physiological network cardiovascular genes localized to the densest layers ( Figure 2D ). This structural property of cardiovascular genes in the context of LVH phenotypes may be used to identify additional genes involved in cardiac function. 24 Next, we expanded the functional characterization of coexpressed genes using enrichment analysis of genes that appear only in pathological (n=1980) or physiological (n=1502) network. The pathological-specific group had a predominance of genes involved in metabolic, apoptotic, and energy production processes, with subcellular localization to mitochondria and extracellular region. In contrast, physiological-specific genes were involved in processes including angiogenesis and cell cycle ( Table V in the online-only Data Supplement). Similar enrichment analysis for all pathological and physiological network genes is shown in Table VI in the online-only Data Supplement.
Topological Properties of Gene Networks
We first assessed the stability of the pathological and physiological networks to targeted removal of hubs (simulated attack) or random nodes (simulated error). 25 Although removal of hubs (attack) had little effect on the pathological network, the physiological network rapidly collapsed into smaller subnetworks, reflected by increasing network diameter ( Figure 3A ). This suggests an unexpected level of robustness of gene coexpressions in the pathological network. Removal of random genes (error) had no effect on either network diameter ( Figure 3A) .
Comparison of global topologies demonstrated that the pathological network is denser than the physiological network (density 0.002 versus 0.0009), with a lower network diameter (20 versus 25) . Local topological properties of the networks are shown in Figure 3A -3F and listed in Tables III and IV in the online-only Data Supplement. Overall, the pathological network had a larger average node degree (7.5 versus 2.8), eigencentrality (0.03 versus 0.01), and clustering coefficient (0.11 versus 0.06) but smaller betweenness (5921.8 versus 6573) and average shortest path length (5.7 versus 9.2; Figure 3A -3F). This topological comparison suggests that the genes under pathological stress form more coexpression links, yielding a dense and robust network. This phenomenon could reflect tight transcriptional regulation under pathological conditions. 26
Identification of Gene Rewiring
When the pathological and physiological networks were compared on a coexpression level, 1654 (46%) of 3634 genes in the pathological network were also present in the physiological network. However, despite this large number of common genes, the 2 networks shared only 60 coexpression links ( Figure III in the online-only Data Supplement). We further assessed topological overlap between pathological and physiological networks at the gene community level. For each network, gene communities were identified by optimizing network modularity (Methods in the online-only Data Supplement). 23 Similarity between gene communities was expressed using Jaccard coefficient, computed as a ratio of the number of common genes in any 2 pathological and physiological network communities to the total number of genes in these communities. Disparate and identical communities would correspond to Jaccard coefficient of 0 and 1, respectively. On average, Jaccard coefficient for 350 and 411 communities in the pathological and physiological networks, respectively, was 0.0002. Therefore, pathological and physiological networks do not share common topologies at either individual gene coexpression level or gene community level. Most of the shared coexpressions were between genes encoding ECM proteins (eg, Col1a1, Col4a1, Col5a2, Col6a2, and Serpinf1).
Because of the low frequency of common coexpressions between pathological and physiological networks, it is likely that a significant subset of hypertrophy-associated genes is subject to differential coexpression, or rewiring, in response to pathological stress. Consequently, differentially wired genes may contribute to phenotypic differences between pathological and physiological LVH. To construct the rewired network, subnetworks consisting of 1654 genes shared by the pathological and physiological interactomes were extracted and then merged. Because several genes were singletons (single nodes without additional coexpressions), the rewired network was reduced to 1553 genes connected by 6197 links (Figure 4A ).
For each rewired gene, we calculated a differential wiring score (see Methods; Figure 4B ). A score >0 indicates that a gene is more connected in the pathological network whereas a score <0 indicates greater connectivity in the physiological network. Overall, 539 and 1014 genes had positive and negative differential wiring scores, respectively ( Table VII in the online-only Data Supplement). Other parameters of local network topology (eg, betweenness centrality) are also reported in Table VII in the online-only Data Supplement.
Experimental Validation of Differentially Wired Genes
Gene rewiring can be interpreted as acquisition or loss of coexpression links in a stimulus-dependent manner. This is a direct consequence of changes in gene expression. To experimentally validate implication of differentially wired genes in LVH phenotypes, we used quantitative polymerase chain reaction to measure expression profiles of 10 rewired genes, namely, Col1a1, Col4a1, Col5a2, Paip2b, Phtf2, Prps1, Rnf14, Serpinh1, Sparc, and Tiprl (Table 2), in mouse models of pathological (AC, n=6) and physiological (treadmill, n=6) LVH and corresponding controls (WT-sham, n=5; WTsedentary, n=5; Figure IV in the online-only Data Supplement). These genes were selected to reflect diverse ranges of differential wiring, and their respective fold changes in the microarray were not considered ( Figure 4B ; Table 2 ). Differential expression analysis confirmed that all transcripts, with the exception of Rnf14, were significantly changed in AC compared with sham-operated controls (4 downregulated, 5 upregulated; P<0.05; Table 3 ; Figure 4C ). Indeed, Rnf14 had a low degree of rewiring of −0.002. Importantly, none of the transcripts was differentially expressed in physiological LVH compared with WT hearts (Figure 4C ), which is consistent with our computational evidence of rewiring in manifestation of pathological LVH.
Functional Characteristics of Rewired Genes
Given that differentially wired genes may reflect potentially important contributors to the pathological LVH phenotype, we further analyzed these genes. Using gene mutation information from the Mouse Genome Informatics database, it was noted that the rewired network included 241 (16%) genes in which null mutations result in cardiac phenotypes (eg, interleukin-1 receptor-associated kinase 1, superoxide dismutase, and vascular endothelial growth factor B). In addition, cardiovascular system phenotype and abnormal cardiovascular morphology were the most enriched phenotypes (adjusted P=6.3×10 −4 and 1.9×10 −3 ; Figure V in the online-only Data Supplement). Gene set enrichment of all rewired genes for Reactome pathways, as well as gene ontology biological process and gene ontology cellular component terms, revealed several distinct functional groups (Table 3) , including major histocompatibility complex class II antigen presentation and tricarboxylic acid cycle and respiratory electron transport pathways with cellular localization to ECM, mitochondrial part, and stress fiber.
Functional enrichment of genes in the top 25th percentile of differential wiring (n=388 genes) identified gene ontology biological process terms such as hydrogen peroxide metabolic process and positive regulation of macroautophagy (Table  VIII in the online-only Data Supplement). Interestingly, genes in the bottom 25th percentile of differential wiring were not significantly enriched. The above computational analysis and quantitative polymerase chain reaction validation suggest that genes localized to the ECM and myofilaments, among others, are differentially wired in pathological LVH. Thus, we further explored these findings using a proteomic approach. LVs were obtained from 2 murine models of pathological hypertrophy-angiotensin II infusion (n=4) and AC (n=4)-and sham-operated controls (n=4). To enable a better characterization of myofilament and ECM proteins, we enriched for these subproteomes using solubility-based protein subfractionation methodologies (see Methods in the online-only Data Supplement). 19, 20 Western blotting of the subfractions confirmed that the extracts were rich in myofilament (eg, troponin I type 3 [TNNI3_ MOUSE]) and extracellular proteins (eg, collagen α-2 [VI]
[CO6A2_MOUSE], glutathione peroxidase 3) whereas membrane and cytosolic proteins (eg, ITA8_MOUSE, β-actin [ACTB_MOUSE]) were depleted ( Figure 5A ). Subsequently, the enriched extracts were separated by SDS-PAGE, subjected to in-gel tryptic digestion, and analyzed by liquid chromatography-tandem mass spectrometry (see Methods). Two complementary approaches, spectral counting and peptide ion intensities, were used to estimate protein abundance. Quantitative information is available from both methods, which produced comparable results ( Figure VI and Data Sets I and II in the online-only Data Supplement). For subsequent analysis, we focused on spectral counting-based quantification, given its greater dynamic range than peptide ion intensities (2268 versus 385 proteins). Principal component analysis of 1300 proteins that passed filtering criteria (Methods in the online-only Data Supplement) in the proteomic data revealed a separation of sham-operated controls and hypertrophic samples ( Figure 5B ). Enrichment of 1300 proteins for gene ontology cellular component terms confirmed successful enrichment for myofilament (n=68) and extracellular (n=100) proteins in the extracted subproteome. In addition, mitochondrial proteins were also detected (n=292; Figure 5C ). Spectral count information for the different subproteomes is visualized in Figure 5D and listed in Table IX in the online-only Data Supplement. Overall, 12 of 30 (40%), 80 of 226 (35%), and 22 of 102 (22%) rewired genes that were predicted to be myofilament, mitochondrial, and extracellular were also quantified by proteomics.
To define the relationship between changes in gene expression and protein levels, we correlated protein and mRNA expression ratios using PCC. We used the pathological microarray cohort (AC1, AC2, angiotensin II receptor type 1 data sets; Table 1) to identify 2796 mRNAs with consistent changes compared with controls across all data sets. Similarly, we identified 170 proteins with consistent changes in AC and angiotensin subproteomes compared with sham-operated mice. Subsequently, 170 protein-transcript pairs were compared using respective fold changes compared with normal, revealing a significant but relatively modest positive correlation between the proteomic and transcriptomic changes (PCC=0.25; P=0.0008; Figure 6A ). Although the spectral counts of the mitochondrial subproteome did not correlate with mRNA expression (PCC=−0.19; P=0.11), myofilament and extracellular subproteomes showed stronger positive correlation (PCC=0.52; P=0.16 and PCC=0.56; P=0.03, respectively; Figures 6A) . Quantitative information for mRNA-protein relationships is listed in Table X in the online-only Data Supplement. Furthermore, we calculated average fold changes of mRNAs and proteins that mapped to unique Reactome 27 pathways (289 pathways represented by 631 mRNA-protein pairs). When considered the Reactome pathway level, mRNA-protein correlation was much stronger (PCC=0.74; P=2.2×10 −16 ) and across upregulated pathways such as chondroitin sulfate dermatan sulfate metabolism, chondroitin sulfate and dermatan sulfate degradation, and endothelial nitric oxide synthase activation and regulation and downregulated pathways, including S phase and antigen processing-cross presentation ( Figure 6B ; Table XI in the online-only Data Supplement).
Discussion
We used a combined gene network and proteomic approach to characterize pathological and physiological LVH phenotypes on a systems-wide level. This analysis shows that pathological and physiological network topologies are significantly different, with the notable finding that there is differential gene wiring in pathological versus physiological stress. This coexpression rewiring captures differences in metabolic and energy production processes, contractile fibril organization, and ECM turnover, being highly consistent with the phenotype studied. Furthermore, many of these pathways were experimentally explored at the proteome level. This network biology approach contributes novel insights into the integrated mechanisms of pathological LVH and heart failure.
Cardiac Gene Networks
Several studies have compared gene expression profiles in pathological and physiological LVH using microarray experiments. 28 However, there seems to be a large discrepancy in the number of genes and types of signaling pathways reported for these phenotypes. One reason may be variability in statistical prioritization of significantly regulated genes. 29 Thus, a comprehensive network-based meta-analysis of cardiac transcriptomes as presented here has advantages compared with conventional statistical approaches (eg, t test or ANOVA). In this study, we included relevant transcript expression data sets with multiple replicates to reduce noise. We also used an automated method for reverse engineering coexpression networks, thus eliminating selection bias typically associated with conventional statistical analysis of differential expression. Importantly, our data were combined at the level of correlation matrices rather than gene expression levels, which facilitates between-study comparisons and improves functional relevance of identified coexpressed genes. 30 Functional enrichment of the pathological and physiological networks revealed significant over-representation of genes implicated in cardiovascular system phenotypes and features consistent with previous studies that reported altered fatty acid metabolism, cellular apoptosis, sarcomeric organization, and protein synthesis in pathological LVH 31 and upregulation of cell survival, autophagy, and angiogenesis in physiological LVH. 11 These findings suggest that gene network profiling captures the underlying biology of hypertrophy phenotypes.
Evaluation of gene connectivity patterns (ie, network topology) provides additional insights into organizational principles of gene networks. Compared with the physiological network, the pathological LVH network was characterized by shorter average path length and higher average node degree. Although the connectivity of either pathological or physiological network was unaffected by removal of random genes, the physiological interactome collapsed in response to the removal of hub genes whereas the pathological network remained intact. These findings suggest that under pathological stress, genes have considerably more coexpression links than under physiological stress. Biologically, this may reflect differences in transcriptional regulation between LVH phenotypes. 26 Recently, Dewey et al 8 undertook a gene coexpression network analysis of pathological LVH, focusing on the extent of recapitulation of fetal gene expression programs, and could identify specific modules active during both development and disease. In contrast to that study and our previous coexpression analysis of LVH, 32 in the current work, a major focus was the differential network topology comparison of pathological versus physiological LVH. The current analysis reveals that a substantial number of genes (1553) are differentially wired in pathological compared with physiological LVH. Furthermore, several functional groups of rewired genes could be identified, including those involved in electron transport, myofilament organization, and ECM remodeling. Conceptually, gene rewiring can be regarded as the acquisition or loss of coexpression links in a stimulus-dependent manner. Therefore, rewiring is a direct result of changes in expression within the network. We experimentally validated the rewiring of 10 genes involved in ECM organization (Col1a1, Col4a1, Col5a2, Sparc), stress response (Serpinh1), and transcription and translation (Paip2b, Phtf2, Prps1, Rnf14, Tiprl) by confirming differential transcript expression of all rewired genes in pathological but not exercise models of cardiac hypertrophy. In addition, we observed no differential expression for Rnf14, a poorly rewired transcript. The functional groups of rewired genes that have been identified (Table 3) include those known to be involved in pathological LVH (eg, ECM genes, tricarboxylic acid cycle cycle, generation of precursor metabolites) 33 and other categories whose function in pathological LVH has not been previously defined (eg, regulation of RNA splicing, amino acid and derivative metabolism). This suggests that the differential wiring analysis can facilitate identification of novel molecular pathways in pathological LVH. For example, Paip2b-encoded (poly(A)binding protein-interacting protein 2B) protein displaces poly(A)binding protein from the poly(A) tail of capped/polyadenylated mRNAs, thereby inhibiting translation. 34 Observed downregulation of Paip2b in pathological LVH samples is consistent with increased protein turnover in pathological LVH. 35 The cellular function of the Tiprl (TIP41, target of rapmycin signaling pathway regulator-like) gene has not been studied in the heart, but it was recently shown to inhibit mitogen activated protein kinase kinase7 -c-Jun N-terminal kinase activity in hepatocellular carcinoma through type 2A phosphatases. 36 Consideration of gene rewiring may be a useful adjunct to traditional differential expression profiling approaches such as magnitude of fold change for several reasons. First, rewired genes are identified using data-driven analysis that, unlike differential expression profiling, does not depend on introduction of rigid significance thresholds. This is an important advantage given that predefined statistical thresholds may significantly alter microarray interpretation. 29 Second, because data sets are compared at the level of coexpression matrices, rewiring may be more sensitive to subtle expression changes, which are otherwise missed during conventional statistical comparison.
Finally, evaluation of rewiring patterns may uncover spatial relationships across gene neighborhoods, identifying higherlevel biologically relevant pathways, thus presenting additional level of information within a microarray experiment.
Gene-Protein Relationships
An important issue is the magnitude of correlation between changes in mRNA and protein levels, which may reflect the relative importance of transcriptional regulation versus other mechanisms. To address this, we undertook a proteomics analysis focused on defined functional groups identified from the rewired gene network of pathological LVH. We analyzed the ECM and myofilament subproteome because functional gene groups encoding proteins involved in regulating these structures were identified as differentially rewired. The method used to enrich the extracellular and myofilament proteome also enriched mitochondrial proteins, which was another functional category identified as rewired. Although proteomics cannot provide a global analysis of all expressed cardiac proteins, focusing on a subproteome allowed us to identify 12 of 30 (40%), 80 of 226 (35%), and 22 of 102 (22%) rewired genes in myofilament, mitochondrial, and extracellular subproteomes. This finding confirms that enriching for specific subproteomes enhances the confidence of protein quantification. 37 We found a modest positive correlation between changes in mRNA levels and protein abundance when assessing these at the individual gene level, especially for the specifically enriched subproteomes (myofilament and extracellular). This could be taken to indicate that nontranscriptional mechanisms, such as alterations in protein stability, are at least as important as transcriptional regulation. However, we found that mRNAprotein relationships analyzed at the Reactome pathway level were substantially stronger. This striking finding suggests that the expression of entire pathways may be controlled at the transcriptional level 38 and could, in part, be a manifestation of other mechanisms such as microRNA-mediated regulation. 39 In addition to validating the potential of network biology and differential wiring analyses to identify real biological changes in protein abundance, this finding also suggests that the network approach may identify pathways that may not be readily detected by conventional comparisons of microarray profiles. Pathways found to be correlated at the mRNA-protein level included several known to be involved in the regulation of LVH, such as upregulation of chondroitin sulfate metabolism 40 and the endothelial nitric oxide synthase pathway 41 and downregulation of S phase 42 and antigen processing-cross presentation 43 pathways.
Conclusions
Overall, our results represent a first attempt to provide insights into the integrated molecular mechanisms of pathological versus physiological cardiac hypertrophy by representing transcriptomic and proteomic data as biological networks. The methodology that we have developed is freely accessible at http://sites.google.com/site/cardionetworks. With the increasing availability of comprehensive omics data sets in the public domain, analytic approaches described herein may be useful for the elucidation of both general and specific mechanisms of cardiac diseases. Future expansion and modification of such methodology may be valuable in developing new therapeutic strategies or biomarkers. 
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